Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

A study to establish the technical and economic feasibility of a mobile DNA and RNA testing tool, for use in general clinics and homecare.

Objectif

As DNA testing is most commonly centralised in labs, it lacks the turnaround time for time-sensitive applications, and also lacks mobility. The experience in biology required to prepare samples and carry out testing obfuscate the process and limit point-of-care applications. Biomeme seeks to break down these barriers with their versatile Dx System, a holistic solution to bring DNA testing out of the labs and into the physician’s office. Thus, Biomeme provides Molecular Diagnostics for the on-demand economy. By simplifying the process of DNA testing, without sacrificing the detail to be found in raw data, the Biomeme solution brings molecular diagnostic into point-of-care medical services, making it available for homecare and other point-of-need uses.

Champ scientifique (EuroSciVoc)

Programme(s)

Thème(s)

Régime de financement

SME-1 - SME instrument phase 1

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) H2020-SMEInst-2016-2017

Voir tous les projets financés au titre de cet appel

Coordinateur

BIOMEME UK LTD
Contribution nette de l'UE
€ 50 000,00
Adresse
72 GREAT SUFFOLK STREET
SE1 0BL LONDON
Royaume-Uni
PME
Oui
Région
London Inner London — East Lewisham and Southwark
Type d’activité
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Liens
Coût total
€ 71 429,00

Participants (1)